Molecular Studies in Incontinentia Pigmenti Patients
Author Information
Author(s): Seema Thakur, Ratna D. Kohli, Sudha Saxena, Renu Verma
Primary Institution: Sir Ganga Ram Hospital, New Delhi, India
Hypothesis
Molecular studies can improve the diagnosis and genetic counseling of incontinentia pigmenti (IP).
Conclusion
Molecular diagnosis is essential for confirming clinical suspicion and providing accurate genetic counseling and prenatal diagnosis for incontinentia pigmenti.
Supporting Evidence
- Molecular studies confirmed the diagnosis in all four cases of incontinentia pigmenti.
- Two mothers were identified as carriers of the NEMO gene mutation.
- Prenatal diagnosis was provided for ongoing pregnancies in affected families.
Takeaway
This study looked at four families with a skin condition called incontinentia pigmenti and found that genetic testing helped confirm the diagnosis and identify carriers.
Methodology
Molecular studies were conducted using DNA isolated from peripheral blood, with deletion analysis of the NEMO gene performed through multiplex PCR.
Limitations
The study is limited by the small sample size and the variability in clinical presentation of the disorder.
Participant Demographics
The study included four families with affected daughters and their mothers, with ages ranging from 2 to 33 years.
Want to read the original?
Access the complete publication on the publisher's website